Clinical trial
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in…
NCT00094822 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00094822 |
|---|---|
| Title | Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Pegfilgrastim Given Same Day as or Day After Carboplatin and Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Cancer, Non-Small Cell Lung Cancer |
| Intervention type | Other |
| Interventions | PI Discretion |
| Enrollment | 90 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Oct 27, 2004 |
| Last update posted | Feb 13, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: